On January 26, 2026, the prestigious Dual Ten announcement ceremony was held at the Academic Hall of the Chinese Academy of Sciences. The achievement Chinese Liver Cancer Prediction System Featured on Nature Cover and Serves Global Community, led by Professor Sun Cheng's team from USTC's School of Life Sciences and Medicine, was selected as one of the Top Ten Scientific and Technological Advances in China for 2025 by academicians of the Chinese Academy of Sciences and Chinese Academy of Engineering. Professor Sun attended the ceremony in Beijing to receive the commemorative certificate and plaque.
The Dual Ten selection—Top Ten Scientific and Technological Advances in China/World—is co-hosted by the Chinese Academy of Sciences and Chinese Academy of Engineering, and organized by the Department of Academic Affairs of CAS and China Science Daily. As one of China's longest-running and most authoritative science communication initiatives, now in its 31st year, the selection represents the nation's most significant scientific breakthroughs and cutting-edge achievements of the year, distinguished by both academic excellence and societal impact.
The selected liver cancer prediction system represents a revolutionary breakthrough by Professor Sun's team in addressing the critical clinical challenge of post-surgical liver cancer recurrence. Through in-depth investigation of spatial distribution patterns of immune cells within the tumor microenvironment, the team revealed core associations with patient prognosis and innovatively developed the TIMES (Tumor Immune Microenvironment Spatial) scoring system. Leveraging advanced technology, this system enables precise assessment of post-surgical recurrence risk in liver cancer patients. It not only provides novel academic perspectives for tumor immune microenvironment research but also serves as a potential cornerstone tool for precision post-operative management of liver cancer patients, contributing Chinese innovation and solutions to the global liver cancer treatment landscape.
Published as the cover story in Nature, the research has generated substantial international academic impact and has been adopted by over 3,000 researchers across 45 countries worldwide.
As a national-level scientific honor, this selection represents high recognition of the Sun Cheng team's research innovation capabilities and achievement value, and demonstrates USTC's leadership position at the frontiers of interdisciplinary life sciences and medicine. The Sun Cheng team states that they will leverage this recognition to continue advancing translational research and clinical applications, making greater contributions to improving liver cancer diagnosis and treatment standards in China and globally, and safeguarding human health.

